OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,451,000 | -1.0% | 499,193 | 0.0% | 0.02% | +9.1% |
Q3 2016 | $2,476,000 | -2.6% | 499,193 | 0.0% | 0.02% | -18.5% |
Q2 2016 | $2,541,000 | -10.8% | 499,193 | 0.0% | 0.03% | -10.0% |
Q1 2016 | $2,850,000 | -45.0% | 499,193 | 0.0% | 0.03% | -30.2% |
Q4 2015 | $5,182,000 | -43.8% | 499,193 | 0.0% | 0.04% | -49.4% |
Q3 2015 | $9,220,000 | -5.1% | 499,193 | 0.0% | 0.08% | 0.0% |
Q2 2015 | $9,714,000 | +10.7% | 499,193 | 0.0% | 0.08% | +16.4% |
Q1 2015 | $8,776,000 | +7.5% | 499,193 | -2.2% | 0.07% | -12.0% |
Q4 2014 | $8,165,000 | +27.0% | 510,606 | 0.0% | 0.08% | +2.5% |
Q3 2014 | $6,429,000 | -19.4% | 510,606 | 0.0% | 0.08% | -17.3% |
Q2 2014 | $7,976,000 | +68.0% | 510,606 | +41.2% | 0.10% | +63.3% |
Q1 2014 | $4,747,000 | -21.3% | 361,530 | -3.7% | 0.06% | -29.4% |
Q4 2013 | $6,035,000 | -3.4% | 375,282 | 0.0% | 0.08% | -4.5% |
Q3 2013 | $6,245,000 | – | 375,282 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,035,709 | $37,600,000 | 5.29% |
GREAT POINT PARTNERS LLC | 75,000 | $1,385,000 | 0.55% |
Hood River Capital Management LLC | 204,653 | $3,780,000 | 0.52% |
Timpani Capital Management LLC | 69,640 | $1,286,000 | 0.52% |
RATIONAL ADVISORS LLC | 64,000 | $1,182,000 | 0.48% |
PIPER SANDLER & CO. | 22,000 | $406,000 | 0.43% |
PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $643,000 | 0.39% |
TFS CAPITAL LLC | 101,070 | $1,867,000 | 0.18% |
FALCON POINT CAPITAL, LLC | 26,557 | $491,000 | 0.18% |
EAM Investors, LLC | 56,694 | $1,047,000 | 0.17% |